936. Antibacterial Resistance Patterns and Outcomes after Bacteremia: Does it Really Matter?
Session: Symposium: Questions in Bacteremia
Friday, October 6, 2017: 8:55 AM
Room: 06CF
Brad Spellberg, MD, 2051 Marengo Street, C2K126, LAC+USC Medical Center, Los Angeles, CA


B. Spellberg, Cempra, The Medicines Company, Medimmune, Tetraphase, AstraZeneca, Merck, Genentech, Forge, Pfizer: Consultant , Consulting fee
Motif, BioAIM, Synthetic Biologics, Mycomed: Shareholder , Equity

See more of: Questions in Bacteremia
See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.